• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX27526X
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problems Intimal Dissection (1333); Patient Problem/Medical Problem (2688); Vascular Dissection (3160)
Event Date 05/30/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During the index procedure, three resolute onyx stents were implanted into the lad.A persistent stent edge dissection occurred in the proximal lad and was treated with poba during a staged procedure.The patient recovered.The investigator assessed the event as possibly related to the index device and not related to anti-platelet medication.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Adverse event date updated.The dissection in the proximal lad was caused by resolute onyx des.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Sponsor assessed the event as possibly related to the device and not related to the antiplatelet medication.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Cec assessed event was part of the index procedure.Event definition - no event.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: cec assessed the initial revascularisation as no event as it was part of the index procedure and assessed the stage procedure revascularisation as tlr pci of the lad clinically driven.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Event date changed to the (b)(6) 2018.The patient was not hospitalised.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7742004
MDR Text Key115780254
Report Number9612164-2018-01929
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 07/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2019
Device Catalogue NumberRONYX27526X
Device Lot Number0008853573
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/04/2018
Initial Date FDA Received08/02/2018
Supplement Dates Manufacturer Received08/08/2018
10/12/2018
03/29/2019
05/09/2019
05/28/2019
07/22/2019
Supplement Dates FDA Received10/02/2018
10/19/2018
04/16/2019
05/24/2019
06/19/2019
07/24/2019
Date Device Manufactured10/31/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age59 YR
Patient Weight45
-
-